[{"name":"TUAC0401LB - First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one year \u003Csmall\u003E(ID 851)\u003C\/small\u003E","mode":"","public":true,"info":{"id":851,"presentation":"TUAC0401LB - First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one year \u003Csmall\u003E(ID 851)\u003C\/small\u003E","session":"TUAC04 - Hot off the press: What\u2019s new in HIV prevention \u003Csmall\u003E(ID 132)\u003C\/small\u003E","presenter":"Randolph P. Matthews","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/132\/v\/851_1c.mp4","source_path":"s3:\/\/us-cslide-prod-recordings\/ias2019\/132\/v\/851_1c.mp4","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/132\/51A6F40D.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/132\/v\/851_1c.vtt","thumbnails":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/132\/v\/851_1c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Up0fF"}